Get the Stockscreener App
13.45
0.71%
0.11
Integra Lifesciences Holdings Corp stock is traded at $13.45, with a volume of 18,259.
It is up +0.71% in the last 24 hours and down -10.79% over the past month.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
See More
Previous Close:
$13.34
Open:
$13.48
24h Volume:
18,259
Relative Volume:
0.02
Market Cap:
$1.05B
Revenue:
$1.53B
Net Income/Loss:
$40.23M
P/E Ratio:
26.90
EPS:
0.5
Net Cash Flow:
$60.93M
1W Performance:
-7.34%
1M Performance:
-10.79%
6M Performance:
-20.92%
1Y Performance:
-30.14%
1-Day Range:
$13.43
$13.59
1-Week Range:
$13.18
$14.97
52-Week Range:
$11.06
$27.13
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Name
Integra Lifesciences Holdings Corp
Sector
Industry
Phone
(609) 275-0500
Address
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
13.50 | 1.04B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
132.11 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.87 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
366.35 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.74 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.32 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Upgrade | Argus | Hold → Buy |
| Dec-02-24 | Initiated | Morgan Stanley | Underweight |
| Oct-07-24 | Upgrade | BTIG Research | Sell → Neutral |
| Jul-30-24 | Downgrade | BTIG Research | Neutral → Sell |
| Jul-30-24 | Downgrade | Citigroup | Neutral → Sell |
| May-07-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-03-24 | Upgrade | Citigroup | Sell → Neutral |
| Dec-05-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-23 | Initiated | CL King | Buy |
| Aug-24-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-08-23 | Downgrade | Argus | Buy → Hold |
| May-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Downgrade | Citigroup | Neutral → Sell |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-25-22 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Dec-17-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-15-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-08-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-27-20 | Initiated | Citigroup | Neutral |
| Apr-03-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-03-19 | Initiated | SunTrust | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-07-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-18 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Neutral |
| Jan-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-30-17 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-27-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| May-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-13-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-06-17 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Dec-12-16 | Initiated | UBS | Buy |
View All
Integra Lifesciences Holdings Corp Stock (IART) Latest News
Wealth Enhancement Advisory Services LLC Purchases 1,927 Shares of Integra LifeSciences Holdings Corporation $IART - Defense World
How Integra LifeSciences Holdings Corporation (IL3) stock compares with market leaders2025 Performance Recap & AI Forecast Swing Trade Picks - newser.com
Real time breakdown of Integra LifeSciences Holdings Corporation stock performanceJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Published on: 2025-10-10 04:09:09 - newser.com
Is Integra LifeSciences Holdings Corporation stock positioned for long term growthEarnings Overview Summary & Weekly Sector Rotation Insights - newser.com
Published on: 2025-10-09 06:37:44 - newser.com
Is Integra LifeSciences Holdings Corporation stock reversal real or fakeJuly 2025 Institutional & Risk Controlled Daily Plans - newser.com
Integra LifeSciences (NASDAQ:IART) Receives "Sell (D)" Rating from Weiss Ratings - MarketBeat
What MACD trends signal for Integra LifeSciences Holdings Corporation (IL3) stockJuly 2025 Levels & Real-Time Stock Movement Alerts - newser.com
Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting - Yahoo Finance
Integra LifeSciences Holdings Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
How risky is Integra LifeSciences Holdings Corporation (IL3) stock compared to peersInsider Buying & Expert-Curated Trade Recommendations - newser.com
Is Integra LifeSciences Holdings Corporation (IL3) stock safe for risk averse investorsWeekly Profit Analysis & Low Risk Profit Maximizing Plans - newser.com
Could Integra LifeSciences (IART) Leverage New Clinical Leadership to Advance Its Innovation Agenda? - simplywall.st
How strong dollar benefits Integra LifeSciences Holdings Corporation (IL3) stockJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com
Can Integra LifeSciences Holdings Corporation (IL3) stock deliver consistent EPS growth2025 Technical Patterns & Risk Controlled Daily Trade Plans - newser.com
Why Integra LifeSciences Holdings Corporation stock could see breakout soonJuly 2025 Review & AI Optimized Trade Strategies - newser.com
How Integra LifeSciences Holdings Corporation (IL3) stock trades in high volatilityJuly 2025 Technicals & Safe Entry Trade Reports - newser.com
Integra LifeSciences Holdings Corporation stock momentum explainedMarket Volume Report & Low Drawdown Momentum Trade Ideas - newser.com
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Given Average Recommendation of "Reduce" by Brokerages - MarketBeat
Integra LifeSciences (IART): Assessing Current Valuation After a Recent Share Price Dip - Yahoo Finance
Integra LifeSciences Holdings (IART): Exploring Valuation Opportunities After Recent Share Price Decline - simplywall.st
How resilient is Integra LifeSciences Holdings Corporation stock in market downturnsInflation Watch & Real-Time Buy Signal Alerts - newser.com
What earnings revisions data tells us about Integra LifeSciences Holdings CorporationAnalyst Upgrade & Capital Efficient Trading Techniques - newser.com
How to use a screener to detect Integra LifeSciences Holdings Corporation breakoutsWeekly Earnings Recap & Weekly Top Gainers Trade List - newser.com
Integra LifeSciences (NASDAQ:IART) Stock Price Down 4.1%What's Next? - MarketBeat
Integra LifeSciences Hits Day High with 8.73% Surge in Stock Price - Markets Mojo
Will Integra LifeSciences Holdings Corporation stock beat EPS estimatesJuly 2025 Patterns & Fast Entry and Exit Trade Plans - newser.com
Integra LifeSciences (NASDAQ:IART) Stock Price Up 4.9%What's Next? - MarketBeat
Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know - Barchart.com
Integra Lifesciences Holdings Corp Stock (IART) Financials Data
Revenue
Net Income
Cash Flow
EPS
Integra Lifesciences Holdings Corp Stock (IART) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '25 |
Option Exercise |
0.00 |
1,180 |
0 |
2,359 |
| Schwartz Eric | EVP, Chief Legal Officer & Sec |
Dec 03 '24 |
Sale |
24.59 |
4,070 |
100,102 |
59,511 |
0.87%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):